228 related articles for article (PubMed ID: 7285537)
1. [Synthetic salmon calcitonin in the therapeutic management of osteolytic metastases of breast carcinoma].
Simone C; Racanelli A
Clin Ter; 1981 Aug; 98(3):247-67. PubMed ID: 7285537
[No Abstract] [Full Text] [Related]
2. [Clinical use of calcitonin in the treatment of osseous localizations in breast carcinoma and multiple myeloma].
Di Benedetto G; Corsini G; Puppo F; Zavarise GM
Clin Ter; 1981 Mar; 96(6):605-13. PubMed ID: 7285526
[No Abstract] [Full Text] [Related]
3. Human calcitonin and malignant osteolysis.
Nuti R; Righi G; Turchetti V; Vattimo A; Lazzaretto R; Martini G
Panminerva Med; 1986; 28(1):5-9. PubMed ID: 3960585
[No Abstract] [Full Text] [Related]
4. [Bone targeting agents: bisphosphonates].
Debiais F
Bull Cancer; 2013 Nov; 100(11):1199-206. PubMed ID: 24158668
[TBL] [Abstract][Full Text] [Related]
5. Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion.
Rosen LS; Gordon DH; Dugan W; Major P; Eisenberg PD; Provencher L; Kaminski M; Simeone J; Seaman J; Chen BL; Coleman RE
Cancer; 2004 Jan; 100(1):36-43. PubMed ID: 14692022
[TBL] [Abstract][Full Text] [Related]
6. [The analgesic effect of calcitonin on breast cancer patients with bone metastases].
Kimura M; Abe R
Gan No Rinsho; 1987 Jul; 33(8):921-7. PubMed ID: 3613114
[TBL] [Abstract][Full Text] [Related]
7. [Use of calcitonin in neoplastic osteolysis].
Pastorino G; Bianucci M
Minerva Med; 1983 Mar; 74(13):707-14. PubMed ID: 6835560
[TBL] [Abstract][Full Text] [Related]
8. [Salmon calcitonin in supportive therapy of neoplastic osteolysis. Preliminary report on a case of myeloma].
Andriani A; Beni A; Beni RA; Calistri A; Gelli GF
Clin Ter; 1981 Jan; 96(2):183-91. PubMed ID: 7237953
[No Abstract] [Full Text] [Related]
9. Conventional radiograms for assessment of salm-calcitonin therapy for bone metastases from breast carcinoma.
Geyer J; Quadt C; Perlick E; Starke K; Stier G; Tanneberger S
Eur J Radiol; 1991; 12(2):124-6. PubMed ID: 2036999
[TBL] [Abstract][Full Text] [Related]
10. [Clinical experience with human calcitonin].
De Bastiani G; Nogarin L; Lazzaretto R
Minerva Med; 1981 Jun; 72(26):1719-23. PubMed ID: 6166901
[TBL] [Abstract][Full Text] [Related]
11. Bone metastases and tumor-induced hypercalcemia.
Body JJ
Curr Opin Oncol; 1992 Aug; 4(4):624-31. PubMed ID: 1511019
[TBL] [Abstract][Full Text] [Related]
12. [Thyrocalcitonin, betamethasone and hydration in hypercalcemia caused by bone metastases of breast carcinoma].
Azzoini P
Clin Ter; 1981 Apr; 97(2):147-52. PubMed ID: 7237955
[No Abstract] [Full Text] [Related]
13. Clinical trials in metastatic breast cancer to bone: past--present--future.
Body JJ
Can J Oncol; 1995 Dec; 5 Suppl 1():16-27. PubMed ID: 8853520
[TBL] [Abstract][Full Text] [Related]
14. Role of parathyroid hormone-related peptide in hypercalcemia of malignancy and the development of osteolytic metastases.
de Vernejoul MC
Rev Rhum Engl Ed; 1997 Jun; 64(6 Suppl):119S-123S. PubMed ID: 9273953
[No Abstract] [Full Text] [Related]
15. Agents affecting osteolysis in patients with breast cancer.
Coombes RC; Neville AM; Gazet JC; Ford HT; Nash AG; Baker JW; Powles JT
Cancer Chemother Pharmacol; 1979; 3(1):41-4. PubMed ID: 161206
[No Abstract] [Full Text] [Related]
16. Hypercalcemia and bone resorption in malignancy.
Walls J; Bundred N; Howell A
Clin Orthop Relat Res; 1995 Mar; (312):51-63. PubMed ID: 7634618
[TBL] [Abstract][Full Text] [Related]
17. [Results of calcitonin therapy of the painful symptoms caused by osteolytic metastases of prostatic carcinoma].
Fabris P; Strada G; Tonazzi G; Rossi A; Franchini V; Scardino E
Chir Ital; 1980 Dec; 32(6):1740-4. PubMed ID: 6166404
[TBL] [Abstract][Full Text] [Related]
18. [Role and use of biphosphonates in the treatment of metastatic breast cancer].
Caulin F
Pathol Biol (Paris); 1990 Oct; 38(8):862-3. PubMed ID: 2148817
[No Abstract] [Full Text] [Related]
19. [Reconstruction of metastatically destroyed skeletal parts following radiologic-cytostatic-hormonal and orthopaedic therapy (author's transl)].
Barndt J
Radiobiol Radiother (Berl); 1977; 18(5):619-24. PubMed ID: 609725
[No Abstract] [Full Text] [Related]
20. [Role of diphosphonates in the therapy of osteolysis and malignant hypercalcemia].
Delmas PD; Charhon SA; Chapuy MC; Meunier PJ
Rev Rhum Mal Osteoartic; 1984 Dec; 51(11):663-6. PubMed ID: 6523018
[No Abstract] [Full Text] [Related]
[Next] [New Search]
